Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr1 Inhibitors

Olfr1 (olfactory receptor family 1 subfamily E member 16) interacts with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) and are responsible for the recognition and G protein-mediated transduction of odorant signals. GPCRs are a large family of cell surface receptors that play crucial roles in cellular signal transduction. Their activation by various ligands, including hormones, neurotransmitters, and even sensory stimuli like odors, initiates a cascade of intracellular events. The inhibition of GPCR signaling is a significant area of pharmacological research due to the widespread roles of these receptors in physiological processes. Chemical inhibitors of GPCRs, such as the ones listed, operate through various mechanisms. Some, like propranolol, act as antagonists, blocking the receptor's active site and preventing the binding of natural ligands. Others, like aripiprazole, function as partial agonists or antagonists, modulating the receptor's activity rather than completely inhibiting it. These inhibitors often have high specificity, targeting distinct receptor subtypes, which is crucial for minimizing off-target effects.

The significance of GPCR inhibitors extends across multiple physiological systems. For instance, in the cardiovascular system, drugs like carvedilol and losartan are pivotal in managing conditions like hypertension and heart failure by modulating receptors involved in blood pressure regulation. In the central nervous system, compounds like risperidone and clozapine affect dopamine and serotonin receptors. Furthermore, their role in respiratory diseases is highlighted by agents like salmeterol and tiotropium bromide, which target receptors to alleviate asthma and COPD. Given the complexity and diversity of GPCR-mediated pathways, the development and application of these inhibitors require a deep understanding of receptor pharmacology and signaling mechanisms. While the direct application to Olfr1 is speculative, understanding the broader context of GPCR modulation provides a foundation for exploring potential indirect inhibitors or modulators for this specific receptor.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

A non-selective beta-adrenergic receptor antagonist, inhibiting GPCR signaling by blocking the action of epinephrine and norepinephrine.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

A non-selective beta-blocker and alpha-1 blocker, impacting GPCR-mediated signaling through multiple pathways.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

An alpha-2 adrenergic receptor antagonist, it inhibits GPCRs associated with adrenergic signaling.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

An angiotensin II receptor antagonist, it modulates GPCR activity related to blood pressure regulation.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$82.00
$333.00
1
(0)

A serotonin 5-HT3 receptor antagonist, impacting GPCR signaling in the central nervous system and gastrointestinal tract.

Risperidone

106266-06-2sc-204881
sc-204881A
sc-204881B
sc-204881C
10 mg
50 mg
1 g
5 g
$174.00
$719.00
$1020.00
$2040.00
1
(1)

A dopamine D2 receptor antagonist, it also influences serotonin receptors, affecting multiple GPCR pathways.

Aripiprazole

129722-12-9sc-207300
sc-207300A
sc-207300B
100 mg
1 g
5 g
$179.00
$212.00
$1037.00
3
(1)

A partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at serotonin 5-HT2A receptor, modulating GPCR activity.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

A long-acting beta2-adrenergic agonist, affecting GPCR signaling in the respiratory system.

Clozapine

5786-21-0sc-200402
sc-200402A
sc-200402B
sc-200402C
50 mg
500 mg
5 g
10 g
$69.00
$364.00
$2500.00
$4100.00
11
(1)

An antagonist at various dopamine and serotonin receptors, demonstrating broad GPCR pathway modulation.

Atropine

51-55-8sc-252392
5 g
$204.00
2
(1)

A competitive antagonist for the muscarinic acetylcholine receptors, a class of GPCRs.